Royal DSM has announced that after 20 years on the managing board and almost 13 years as CEO, Feike Sijbesma has decided to step down as CEO and hand over the company’s leadership, as he seeks to pursue other business and personal roles. Sijbesma will formally hand over his responsibilities as CEO on Feb. 15, 2020 to his successors, Geraldine Matchett and Dimitri de Vreeze, and will remain employed by DSM until May 1, 2020, to ensure a smooth transition.
As co-CEOs, Matchett and de Vreeze will maintain the focus on business performance, financial discipline, innovation, sustainability, and people, as DSM continues its journey. Specifically, Matchett will focus on financial management and capital markets communication, capital allocation, talent and culture development, as well as digital strategy and new ways of working. de Vreeze will focus on operational delivery, customer centricity, driving growth and efficiency, as well as innovation and R&D programs. In conjunction with their co-CEO role, Matchett will retain her responsibilities as CFO and de Vreeze will hold the COO responsibilities.
Matchett joined DSM as CFO and managing board member in 2014, while de Vreeze joined the company in 1990, has held multiple business roles, and has been managing board member since 2013.
According to Innova Market Insights’ COVID-19 Consumer Survey (conducted in March 2020), in China, India, and Indonesia, personal concerns center on health, personal income, and the availability of healthcare and products to buy.
Following a long-term diet that’s low in carbohydrates and high in fat and protein from vegetables may reduce the risk of the most common subtype of glaucoma, according to a study published in Eye-Nature.
The U.S. FDA has announced in a letter of enforcement discretion that it does not intend to object to the use of certain qualified health claims regarding consuming certain cranberry products and a reduced risk of recurrent urinary tract infection in healthy women.
Joywell Foods, a food technology company developing a sweet protein portfolio, has announced the closing of a $6.9 million Series A financing round.
Chicago Section IFT Annual Suppliers’ Symposium & Expo
Rosemont, Illinois, United States